Tested Applications
| Positive WB detected in | K-562 cells, Jurkat cells, A549 cells, HeLa cells, HepG2 cells |
| Positive IHC detected in | human lung cancer tissue Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0 |
Recommended dilution
| Application | Dilution |
|---|---|
| Western Blot (WB) | WB : 1:500-1:2000 |
| Immunohistochemistry (IHC) | IHC : 1:750-1:3000 |
| It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
| Sample-dependent, Check data in validation data gallery. | |
Product Information
10692-1-AP targets RPA3 in WB, IHC, ELISA applications and shows reactivity with human samples.
| Tested Reactivity | human |
| Cited Reactivity | human, mouse |
| Host / Isotype | Rabbit / IgG |
| Class | Polyclonal |
| Type | Antibody |
| Immunogen |
CatNo: Ag1065 Product name: Recombinant human RPA3 protein Source: e coli.-derived, PGEX-4T Tag: GST Domain: 1-121 aa of BC005264 Sequence: MVDMMDLPRSRINAGMLAQFIDKPVCFVGRLEKIHPTGKMFILSDGEGKNGTIELMEPLDEEISGIVEVVGRVTAKATILCTSYVQFKEDSHPFDLGLYNEAVKIIHDFPQFYPLGIVQHD Predict reactive species |
| Full Name | replication protein A3, 14kDa |
| Calculated Molecular Weight | 13 kDa |
| Observed Molecular Weight | 14 kDa |
| GenBank Accession Number | BC005264 |
| Gene Symbol | RPA3 |
| Gene ID (NCBI) | 6119 |
| RRID | AB_2269682 |
| Conjugate | Unconjugated |
| Form | Liquid |
| Purification Method | Antigen affinity purification |
| UNIPROT ID | P35244 |
| Storage Buffer | PBS with 0.02% sodium azide and 50% glycerol, pH 7.3. |
| Storage Conditions | Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA. |
Protocols
| Product Specific Protocols | |
|---|---|
| IHC protocol for RPA3 antibody 10692-1-AP | Download protocol |
| WB protocol for RPA3 antibody 10692-1-AP | Download protocol |
| Standard Protocols | |
|---|---|
| Click here to view our Standard Protocols |
Publications
What published studies show
The RPA3 Polyclonal antibody (Cat# 10692-1-AP) has 3 citations. These publications appear in Drug Resistance Updates, International Journal of Molecular Sciences, and Journal of Cell Science. The research fields span cancer drug resistance (specifically genotoxic drug resistance mediated by CSDE1-RPA2 interactions), breast cancer prognosis and drug sensitivity prediction via gene signatures, and cytokinetic abscission involving ESCRT-III dynamics.
| Species | Application | Title |
|---|---|---|
Drug Resist Updat CSDE1 enhances genotoxic drug resistance in cancer by modulating RPA2 through CSDE1-eIF3a regulatory complex | ||
Int J Mol Sci Construction of a Lysine Lactylation- and DNA Damage Repair-Related Gene Signature to Predict the Prognosis and Drug Sensitivity of Breast Cancer Patients.
| ||
J Cell Sci UMAD1 contributes to ESCRT-III dynamic subunit turnover during cytokinetic abscission |





